Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;71(5):291-4.
doi: 10.6061/clinics/2016(05)09.

Effect of a gel containing pilocarpine on vaginal atrophy in castrated rats

Affiliations

Effect of a gel containing pilocarpine on vaginal atrophy in castrated rats

Cristina A de Sousa-Lages et al. Clinics (Sao Paulo). 2016 May.

Abstract

Objectives: To evaluate the effect of Carbopol gel formulations containing pilocarpine on the morphology and morphometry of the vaginal epithelium of castrated rats.

Methods: Thirty-one female Wistar-Hannover rats were randomly divided into four groups: the control Groups I (n=7, rats in persistent estrus; positive controls) and II (n=7, castrated rats, negative controls) and the experimental Groups, III (n=8) and IV (n=9). Persistent estrus (Group I) was achieved with a subcutaneous injection of testosterone propionate on the second postnatal day. At 90 days postnatal, rats in Groups II, III and IV were castrated and treated vaginally for 14 days with Carbopol gel (vehicle alone) or Carbopol gel containing 5% and 15% pilocarpine, respectively. Next, all of the animals were euthanized and their vaginas were removed for histological evaluation. A non-parametric test with a weighted linear regression model was used for data analysis (p<0.05).

Results: The morphological evaluation showed maturation of the vaginal epithelium with keratinization in Group I, whereas signs of vaginal atrophy were present in the rats of the other groups. Morphometric examinations showed mean thickness values of the vaginal epithelium of 195.10±12.23 μm, 30.90±1.14 μm, 28.16±2.98 μm and 29.84±2.30 μm in Groups I, II, III and IV, respectively, with statistically significant differences between Group I and the other three groups (p<0.0001) and no differences between Groups II, III and IV (p=0.0809).

Conclusion: Topical gel formulations containing pilocarpine had no effect on atrophy of the vaginal epithelium in the castrated female rats.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported.

Figures

Figure 1
Figure 1
Photomicrographs of histological sections of the vaginal epithelium of rats. Note the thickness of the vaginal epithelium (E) and keratin in rats in persistent estrus (A) and the thin layer of basal and parabasal cells in the castrated rats of Groups II (vehicle) (B), III (5% pilocarpine) (C) and IV (15% pilocarpine) (D). Original magnification 100x.

References

    1. Ortmann O, Lattrich C. The treatment of climacteric symptoms. Dtsch Arztebl Int. 2012;109((17)):316–23. - PMC - PubMed
    1. Perino A, Calligaro A, Forlani F, Tiberio C, Cucinella G, Svelato A, et al. Vulvo-vaginal atrophy: a new treatment modality using thermo-ablative fractional CO2 laser. Maturitas. 2015;80((3)):296–301. doi: 10.1016/j.maturitas.2014.12.006. - DOI - PubMed
    1. Mac Bride MB, Rhodes DJ, Shuster LT. Vulvovaginal atrophy. Mayo Clin Proc. 2010;85((1)):87–94. doi: 10.4065/mcp.2009.0413. - DOI - PMC - PubMed
    1. Wiseman LR, Faulds D. Oral pilocarpine: a review of its pharmacological properties and clinical potential in xerostomia. Drugs. 1995;49((1)):143–55. doi: 10.2165/00003495-199549010-00010. - DOI - PubMed
    1. Wynn RL. Oral pilocarpine (Salagen): a recently approved salivary stimulant. Gen Dent. 1996;44((1)):26,29–30. - PubMed